The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases

被引:137
作者
Khersonsky, O [1 ]
Tawfik, DS [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
关键词
D O I
10.1074/jbc.M512594200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum paraoxonases (PONs) are calcium-dependent lactonases that catalyze the hydrolysis and formation of a variety of lactones, with a clear preference for lipophilic lactones. However, the lactonase mechanism of mammalian PON1, a high density lipoprotein-associated enzyme that is the most studied family member, remains unclear, and other family members have not been examined at all. We present a kinetic and site-directed mutagenesis study aimed at deciphering the lactonase mechanism of PON1 and PON3. The pH-rate profile determined for the lactonase activity of PON1 indicated an apparent pK(a) of similar to 7.4. We thus explored the role of all amino acids in the PON1 active site that are not directly ligated to the catalytic calcium and that possess an imidazolyl or carboxyl side chain (His(115), His(134), His(184), His(285), Asp(183), and Asp(269)). Extensive site-directed mutagenesis studies in which each amino acid candidate was replaced with all other 19 amino acids were conducted to identify the residue(s) that mediate the lactonase activity of PONs. The results indicate that the lactonase activity of PON1 and PON3 and the esterase activity of PON1 are mediated by the His(115)-His(134) dyad. Notably, the phosphotriesterase activity of PON1, which is a promiscuous activity of this enzyme, is mediated by other residues. To our knowledge, this is one of few examples of a histidine dyad in enzyme active sites and the first example of a hydrolytic enzyme with such a dyad.
引用
收藏
页码:7649 / 7656
页数:8
相关论文
共 31 条
[1]   The FEMA GRAS assessment of lactones used as flavour ingredients [J].
Adams, TB ;
Greer, DB ;
Doull, J ;
Munro, IC ;
Newberne, P ;
Portoghese, PS ;
Smith, RL ;
Wagner, BM ;
Weil, CS ;
Woods, LA ;
Ford, RA .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (04) :249-278
[2]   The 'evolvability' of promiscuous protein functions [J].
Aharoni, A ;
Gaidukov, L ;
Khersonsky, O ;
Gould, SM ;
Roodveldt, C ;
Tawfik, DS .
NATURE GENETICS, 2005, 37 (01) :73-76
[3]   Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization [J].
Aharoni, A ;
Gaidukov, L ;
Yagur, S ;
Toker, L ;
Silman, I ;
Tawfik, DS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :482-487
[4]  
Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
[5]  
Copeland R. A., 2004, ENZYMES PRACTICAL IN
[6]   Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities [J].
Draganov, DI ;
Teiber, JF ;
Speelman, A ;
Osawa, Y ;
Sunahara, R ;
La Du, BN .
JOURNAL OF LIPID RESEARCH, 2005, 46 (06) :1239-1247
[7]   Pharmacogenetics of paraoxonases: a brief review [J].
Draganov, DI ;
La Du, BN .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) :78-88
[8]   The crystal structure of the H48Q active site mutant of human group IIA secreted phospholipase A2 at 1.5 Å resolution provides an insight into the catalytic mechanism [J].
Edwards, SH ;
Thompson, D ;
Baker, SF ;
Wood, SP ;
Wilton, DC .
BIOCHEMISTRY, 2002, 41 (52) :15468-15476
[9]  
FERSHT A, 1999, STRUCTURE MECH PROTE, P423
[10]   High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I [J].
Gaidukov, L ;
Tawfik, DS .
BIOCHEMISTRY, 2005, 44 (35) :11843-11854